drugIndia
Cart
Jubiglim MV 1 Plus Tablet SR

Jubiglim MV 1 Plus Tablet SR

Metformin (500mg) + Glimepiride (1mg) + Voglibose (0.3mg)

Jubilant Life Sciences
Anti-Diabetic
96.00120.0020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 60%
Best Alternative100% Match

Glipohix 513 Tablet SR

Triohix Critical Care

Voglibose 0.3mg
Glipohix 513 Tablet SR

Pack Size

1 units

Price

38.4020% off
Glipohix 513 Tablet SR is 100% same as Jubiglim MV 1 Plus Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹58

that's 60% off!

composition
  1. Voglibose 0.3mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
96.0020% OFF
120.00

About This Medicine

Product description & overview

Jubiglim MV 1 Plus Tablet SR: A Comprehensive Approach to Blood Sugar Management

Jubiglim MV 1 Plus Tablet SR is a once-daily combination medication specifically designed to manage type 2 diabetes. This formulation combines three key ingredients: Glimepiride (1mg), Metformin (500mg), and Voglibose (0.3mg).

Glimepiride: A sulfonylurea, it works by stimulating the release of insulin from the pancreas, improving blood glucose control.
Metformin: A first-line choice for managing type 2 diabetes, it lowers blood sugar levels primarily by reducing hepatic glucose production and increasing insulin sensitivity.
Voglibose: A medication that acts on the digestive system to slow down the absorption of carbohydrates from food into the bloodstream, further enhancing blood glucose control.

Jubiglim MV 1 Plus Tablet SR is suitable for patients who require a comprehensive approach to managing their diabetes, combining various mechanisms to effectively reduce blood sugar levels and improve overall metabolic health. Always consult with your physician or healthcare professional before starting any new medication regimen.

Active composition

Metformin 500 mg

+2 more active ingredients

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Glimepiride1 mg
Voglibose0.3 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Jubiglim MV 1 Plus Tablet SR.

High Risk

Pregnancy

Jubiglim MV 1 Plus Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Jubiglim MV 1 Plus Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Jubiglim MV 1 Plus Tablet SR may be needed. Please consult your doctor. Jubiglim MV 1 Plus Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Jubiglim MV 1 Plus Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Jubiglim MV 1 Plus Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Jubiglim MV 1 Plus Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Jubiglim MV 1 Plus Tablet SR

Products matching your search